ArticleThe Indian journal of medical research2026
Serum uric acid and its association with intrauterine insemination outcomes in women with polycystic ovarian syndrome.
Article in The Indian journal of medical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and objectives Uric acid is associated with many systemic diseases. Recent evidence demonstrated that high serum uric acid levels in polycystic ovary syndrome (PCOS) could lead to a poor prognosis of in-vitro fertilisation. The objective of this study was to explore the association between serum uric acid levels and reproductive outcomes in women with PCOS undergoing intrauterine insemination (IUI) treatment. Methods We included 682 patients with PCOS who underwent IUI treatment between 2015 and 2024. They were stratified into three groups according to the level of serum uric acid: normal (251-360 µmol/L), low (≤250 µmol/L), and high (>360 µmol/L). Pregnancy and obstetric outcomes of patients were evaluated and linked to serum uric acid levels. The primary outcome measures of this study were the clinical pregnancy rate and live birth rate. Secondary outcome measures included the rates of biochemical pregnancy, ectopic pregnancy, miscarriage, and low birth weight. Results There was no significant difference between the three groups with respect to clinical pregnancy rate (23.3% vs. 26.2% vs. 30.4%) and live birth rate (86.2% vs. 81.5% vs. 93.6%). Biochemical pregnancy rate (25.1% vs. 28.2% vs. 35.3%), ectopic pregnancy rate (3.5% vs. 1.9% vs. 3.2%), miscarriage rate (10.4% vs. 16.7% vs. 3.2%), and low-birth-weight rate (14.6% vs. 12.5% vs. 19.4%) were comparable among the three groups.In terms of birth weight, the three study groups showed comparable values (3122.8±81.10 vs. 3095.6±68.96 vs. 3099.5±162.09 g), and no significant difference was observed. These results remained the same after adjusting for baseline clinical characteristics and in-hospital treatment. Interpretation and conclusions Our findings demonstrated that maternal pre-pregnancy serum uric acid level was not significantly related to pregnancy and obstetric outcomes following IUI treatment in women with PCOS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.